From January 1, 2024 to March 31, 2024, the company has repurchased 93,707 shares, representing 0.29% for CAD 0.28 million. With this, the company has completed the repurchase of 93,707 shares, representing 0.29% for CAD 0.28 million under the buyback announced on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CAD | +0.75% |
|
-2.47% | -15.19% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.19% | 77.82M | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B | |
+7.58% | 3.2B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Tranche Update on HLS Therapeutics Inc.'s Equity Buyback Plan announced on November 9, 2023.